Redirecting to original paper in 30 seconds...
Click below to go immediately or wait for automatic redirect
📄 Abstract
Abstract: Age Related Macular Degeneration(AMD) has been one of the most leading causes
of permanent vision impairment in ophthalmology. Though treatments, such as
anti VEGF drugs or photodynamic therapies, were developed to slow down the
degenerative process of AMD, there is still no specific cure to reverse vision
loss caused by AMD. Thus, for AMD, detecting existence of risk factors of AMD
or AMD itself within the patient retina in early stages is a crucial task to
reduce the possibility of vision impairment. Apart from traditional approaches,
deep learning based methods, especially attention mechanism based CNNs and
GradCAM based XAI analysis on OCT scans, exhibited successful performance in
distinguishing AMD retina from normal retinas, making it possible to use AI
driven models to aid medical diagnosis and analysis by ophthalmologists
regarding AMD. However, though having significant success, previous works
mostly focused on prediction performance itself, not pathologies or underlying
causal mechanisms of AMD, which can prohibit intervention analysis on specific
factors or even lead to less reliable decisions. Thus, this paper introduces a
novel causal AMD analysis model: GCVAMD, which incorporates a modified
CausalVAE approach that can extract latent causal factors from only raw OCT
images. By considering causality in AMD detection, GCVAMD enables causal
inference such as treatment simulation or intervention analysis regarding major
risk factors: drusen and neovascularization, while returning informative latent
causal features that can enhance downstream tasks. Results show that through
GCVAMD, drusen status and neovascularization status can be identified with AMD
causal mechanisms in GCVAMD latent spaces, which can in turn be used for
various tasks from AMD detection(classification) to intervention analysis.
Key Contributions
Proposes a modified CausalVAE model (GCVAMD) for detecting and predicting Age-Related Macular Degeneration (AMD) risk factors from OCT scans. It combines deep learning prediction performance with explainable AI (Grad-CAM) to identify pathologies and risk factors, addressing the focus on prediction over pathology in prior work.
Business Value
Enables earlier detection and better risk assessment of AMD, leading to timely interventions, potentially slowing vision loss and improving patient quality of life.